Tianjin TEDA Biomedical Engineering Company Limited (TEDA BIOMEDICAL) aktie
8189.HK
Fördröjd 15 minTEDA BIOMEDICAL
Market Cap
$354,227,392
Om Tianjin TEDA Biomedical Engineering Company Limited (TEDA BIOMEDICAL) aktie
Tianjin TEDA Biomedical Engineering Company Limited, together with its subsidiaries, engages in the research, development, manufacture, and sale of biological compound fertilizer products in the People's Republic of China. It operates through Fertiliser Products, and AI health & elderly care products and services segments. The company's biological compound fertilizer products include active fertilizer, mixture with nitrogen, phosphorus, and potassium with various formulas. It also involved in the provision of integrated elderly and health care; elderly equipment leasing services; elderly-related products sales; warehousing services; processing and licensing of the fertiliser products; sales of gold products for elderly customers, such as gold amulets and bracelets; sales of chips and servers supporting healthcare solutions; research and development of elderly care business; and elderly care consulting, advisory, management, and assessment services. In addition, the company provides and licenses electroencephalography photography (EEG) diagnosis detection services and conducts EEG detection and diagnosis technology services. Further, the company engages in the research, development, manufacture, and application of biomedical science and technology projects; regional soil resources conditioning and remediation research services; provision of soil environmental quality standards research services; development and application of AI medical large model and MaaS platform; AI life and health project expansion; and data cleaning, database, and data intelligence analysis full-process data services. Tianjin TEDA Biomedical Engineering Company Limited was incorporated in 2000 and is headquartered in Tianjin, the People's Republic of China.
Företagsinformation
300457 Tianjin, China
Analytikernas aktierekommendationer
Denna översikt ger en snabb insikt i hur analytiker bedömer aktiens potential baserat på deras senaste analyser och kursmål.